Baseline Characteristics | ICD Therapy | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Age (years) sex | CE | Drug test to exclude Brugada | PES | AS | NSVT | IS | Ind S | Time to 1st AS (months) | Follow-up (months) | AAD during follow-up |
1 | 47,M | Sy-VF | F | SMVT | 6 | 7 | - | - | 4 | 17 | sotalol |
2 | 51,F | CA | F | NI | 7 | 21 | - | - | 1 | 19 | sotalol |
3 | 66,M | CA | AJ | VF | - | - | - | - | - | 5 | - |
4 | 70,F | CA | P | NI | - | - | 6(af) | - | - | 19 | amiodarone |
5 | 46,M | CA | F | NI | - | 1 | 1(af) | - | - | 23 | sotalol |
6 | 20,M | Sy-VF | A | VF | - | - | 3(st-lp) | - | - | 92 | b-blocker |
7 | 46,F | CA | P | VF | - | 120 | - | - | - | 27 | sotalol |
8 | 40,M | CA | A | NSVT | 1 | - | - | - | 13 | 75 | - |
9 | 33,M | Sy-VF | F | NSVT | - | 1 | - | - | - | 19 | - |
10 | 26,M | CA | F | NI | 1 | - | 3(st-lp) | - | 7 | 9 | sotalol |
11 | 33,F | CA | F | NI | - | - | - | - | - | 18 | - |
12 | 50,F | CA | F | SMVT | 6 | - | 1(st) | - | 13 | 86 | flecainide |
13 | 25,M | CA | AJ + P | NSVT | - | 1 | - | - | - | 62 | - |
14 | 36,M | CA | AJ | NI | 2 | - | 2(af) | 4 | 27 | 55 | sotalol |
15 | 58,M | Sy-VF | AJ | NI | - | - | 3(af) | 2 | - | 57 | sotalol |
16 | 44,M | CA | F + P | NI | - | - | - | - | - | 48 | - |
17 | 28,M | Sy-VF | F | VF | 4 | - | 2(st) | - | 18 | 55 | sotalol |
18 | 35,M | Sy-VF | A | SMVT | - | - | - | - | - | 59 | - |